Mayo Clinic's Business Development team, consistently recognized as one of the top commercialization operations among academic medical centers, is expanding its capabilities through a new initiative: the Mayo Venture Partner (MVP) program. In response to the dynamic and evolving healthcare landscape, Mayo Clinic is enlisting industry veterans to create groundbreaking technologies, co-invest in aligned companies and build new ventures from the ground up.
The MVP program brings together seasoned entrepreneurs, investors and executives who will leverage their expertise with Mayo Clinic's world-class research and clinical expertise. These leaders will play a pivotal role in identifying high-potential opportunities across Mayo Clinic's research and clinical practices, forming new companies and accelerating innovations that advance patient care.
The inaugural MVPs are:
- Amy DuRoss - Healthcare innovation leader with deep expertise in policy, commercialization and diagnostics.
- Audrey Greenberg - Company builder, executive leader and expert in launching and scaling ventures across life sciences, healthcare and other industries.
- Brian Poger - Serial entrepreneur and venture strategist with a track record in digital health and healthcare services.
Working in close partnership with the Mayo Clinic Business Development team, the MVPs will help forge strategic collaborations and deliver real-world impact, underscoring Mayo Clinic's enduring commitment to transforming healthcare.
To date, the Business Development team has returned more than $1.2B in revenue to Mayo Clinic to support its clinical practice, education and research. Additionally, the team has helped create more than 180 companies, licensed 4,848 Mayo Clinic-created technologies through 2,913 agreements, and issued 4,159 patents.
This program and these efforts align with Mayo Clinic's vision to transform healthcare by:
- Accelerating innovation - Turning cutting-edge research, data and other resources into real-world solutions for patients.
- Enhancing patient care - Bringing new treatments and technologies to patients that offer cures and the ability to connect with the healthcare system in ways that increase access and decrease costs.
- Building strategic partnerships - Leveraging external expertise and resources to amplify impact.
Mayo Clinic is dedicated to driving progress and expanding its impact through innovation. This initiative is an exciting opportunity for investors, CEOs and innovators to collaborate with Mayo Clinic and be part of a future that prioritizes patient-centric, transformative healthcare solutions.
More about the MVPs:
Amy DuRoss
Amy is a Mayo Venture Partner focused on launching and scaling companies at the intersection of life sciences, software, and biopharma services. She has spent her career advancing therapies and technologies that improve patient outcomes and expand access to innovation. Amy was co-founder and CEO of Vineti, a pioneer in advanced therapy supply chain software, and held senior leadership roles at GE Ventures and Navigenics. She played a key role in creating California's $8.5 billion stem cell initiative (Proposition 71) and served as chief of staff at the California Institute for Regenerative Medicine (CIRM). Amy serves on several boards across life sciences and biopharma services, is a Health Innovator Fellow at the Aspen Institute, and holds MBA and MA/BA degrees from Stanford University.
Audrey Greenberg
Audrey is a Mayo Venture Partner with deep experience in biotech entrepreneurship and global platform development who has built and scaled companies at the forefront of healthcare innovation. Audrey co-founded the Center for Breakthrough Medicines (CBM), a global leader in cell and gene therapy manufacturing. Under her leadership, CBM raised $500 million, launched 350,000 square feet of GMP space, formed a $100 million joint venture with the University of Pennsylvania, and was acquired by SK pharmteco. She went on to lead commercial strategy for SK pharmteco's 2,000-person global organization. Earlier in her career, Audrey was a private equity executive and investment banker managing over $90 billion in AUM. She is widely recognized for her leadership in life sciences and serves on public, private, and nonprofit boards. Audrey is a CPA and holds an MBA from Wharton.
Brian Poger
Brian is a Mayo Venture Partner helping launch companies rooted in Mayo Clinic science. He has dedicated his career to improving patient outcomes and making healthcare more affordable. Brian was founding CEO of Senior Educators (now Alight Health Exchange) and Benefitter, a widely used benefits platform for small businesses. He held leadership roles at Aon, HealthMarkets, and UnitedHealthcare following the acquisitions of his startups. Most recently, he served as an executive in residence at Frazier Healthcare Partners. Brian began his career at Eli Lilly and McKinsey & Company. He holds an MBA with distinction from Kellogg and a Bachelor of Science in Engineering, magna cum laude, from Washington University in St. Louis.
To learn more, visit the Mayo Clinic Business Development website and subscribe to its e-newsletter and follow the Mayo Clinic Ventures LinkedIn page.
